Gillian Sudlow

3.6k total citations · 2 hit papers
14 papers, 3.3k citations indexed

About

Gillian Sudlow is a scholar working on Molecular Biology, Oncology and Infectious Diseases. According to data from OpenAlex, Gillian Sudlow has authored 14 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Infectious Diseases. Recurrent topics in Gillian Sudlow's work include Protein Interaction Studies and Fluorescence Analysis (8 papers), Drug Transport and Resistance Mechanisms (4 papers) and Pharmacogenetics and Drug Metabolism (3 papers). Gillian Sudlow is often cited by papers focused on Protein Interaction Studies and Fluorescence Analysis (8 papers), Drug Transport and Resistance Mechanisms (4 papers) and Pharmacogenetics and Drug Metabolism (3 papers). Gillian Sudlow collaborates with scholars based in Australia, United States and South Korea. Gillian Sudlow's co-authors include D. N. Wade, D. J. Birkett, Donald Birkett, Peter Goldman, Ronald L. Koch, Ewan J. T. Chrystal, Bernard B. Beaulieu, Martha A. McLafferty, Susan M. Pond and Garry G. Graham and has published in prestigious journals such as Critical Care Medicine, Biochemical Pharmacology and Molecular Pharmacology.

In The Last Decade

Gillian Sudlow

14 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Characterization of Two Specific Drug Binding Sites on Human Serum Albumin

1975 1.5k citations Gillian Sudlow, D. J. Birkett et al. Molecular Pharmacology profile →
Further Characterization of Specific Drug Binding Sites on Human Serum Albumin

1976 1.3k citations Gillian Sudlow, D. J. Birkett et al. Molecular Pharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gillian Sudlow Australia	12	2.7k	1.4k	553	493	445	14	3.3k
D. J. Birkett Australia	19	2.7k 1.0×	1.6k 1.2×	580 1.0×	488 1.0×	434 1.0×	38	3.7k
Ananyo A. Bhattacharya United Kingdom	9	3.6k 1.3×	1.6k 1.1×	652 1.2×	570 1.2×	619 1.4×	10	4.4k
I. Petitpas France	13	2.8k 1.0×	1.3k 0.9×	496 0.9×	437 0.9×	483 1.1×	13	3.6k
J. Ghuman United Kingdom	6	2.2k 0.8×	1.0k 0.7×	368 0.7×	326 0.7×	412 0.9×	6	2.7k
Ulrich Kragh‐Hansen Denmark	39	5.4k 2.0×	2.1k 1.5×	934 1.7×	810 1.6×	756 1.7×	116	7.1k
David P. Cistola United States	35	2.6k 0.9×	874 0.6×	421 0.8×	378 0.8×	302 0.7×	76	3.9k
Ferenc Zsila Hungary	30	2.1k 0.8×	696 0.5×	413 0.7×	684 1.4×	332 0.7×	128	3.6k
Gabriella Fanali Italy	24	2.5k 0.9×	914 0.6×	281 0.5×	280 0.6×	438 1.0×	43	3.6k
Keishi Yamasaki Japan	30	1.8k 0.7×	895 0.6×	285 0.5×	224 0.5×	274 0.6×	127	3.0k
Monica Galliano Italy	29	2.3k 0.8×	558 0.4×	432 0.8×	146 0.3×	250 0.6×	103	3.1k

Countries citing papers authored by Gillian Sudlow

Since Specialization

Citations

This map shows the geographic impact of Gillian Sudlow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gillian Sudlow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gillian Sudlow more than expected).

Fields of papers citing papers by Gillian Sudlow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gillian Sudlow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gillian Sudlow. The network helps show where Gillian Sudlow may publish in the future.

Co-authorship network of co-authors of Gillian Sudlow

This figure shows the co-authorship network connecting the top 25 collaborators of Gillian Sudlow. A scholar is included among the top collaborators of Gillian Sudlow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gillian Sudlow. Gillian Sudlow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Goldman, Peter, Ronald L. Koch, Ewan J. T. Chrystal, et al.. (1986). Comparing the reduction of nitroimidazoles in bacteria and mammalian tissues and relating it to biological activity. Biochemical Pharmacology. 35(1). 43–51. 54 indexed citations

Sudlow, Gillian, et al.. (1983). Reduction of nitroheterocyclic compounds by mammalian tissues in vivo. Biochemical Pharmacology. 32(14). 2249–2253. 24 indexed citations

Sudlow, Gillian, et al.. (1982). Modification of the Hemoccult slide test for occult blood in gastric juice. Critical Care Medicine. 10(10). 692–693. 7 indexed citations

Birkett, D. J., et al.. (1980). Fluorescent probe studies of albumin binding sites. 17(2). 3 indexed citations

Birkett, Donald, et al.. (1978). The fatty acid content and drug binding characteristics of commercial albumin preparations. Clinica Chimica Acta. 85(3). 253–258. 33 indexed citations

Birkett, Donald, et al.. (1977). Effects of Fatty Acids on Two Specific Drug Binding Sites on Human Serum Albumin. Molecular Pharmacology. 13(6). 987–992. 83 indexed citations

Sudlow, Gillian, D. J. Birkett, & D. N. Wade. (1976). Further Characterization of Specific Drug Binding Sites on Human Serum Albumin. Molecular Pharmacology. 12(6). 1052–1061. 1341 indexed citations breakdown →

Sudlow, Gillian, D. J. Birkett, & D. N. Wade. (1975). The Characterization of Two Specific Drug Binding Sites on Human Serum Albumin. Molecular Pharmacology. 11(6). 824–832. 1533 indexed citations breakdown →

Sudlow, Gillian, Donald Birkett, & D. N. Wade. (1975). Spectroscopic techniques in the study of protein binding. A fluorescence technique for the evaluation of the albumin binding and displacement of warfarin and warfarin‐alcohol. Clinical and Experimental Pharmacology and Physiology. 2(2). 129–140. 83 indexed citations

10.

Pond, Susan M., Garry G. Graham, D. N. Wade, & Gillian Sudlow. (1975). The Effects of Allopurinol and Clofibrate on the Elimination of Coumarin Anticoagulants in Man. Australian and New Zealand Journal of Medicine. 5(4). 324–328. 22 indexed citations

11.

Sudlow, Gillian, Donald Birkett, & D. N. Wade. (1973). Spectroscopic Techniques in the Study of Protein Binding: The Use of 1-Anilino-8-naphthalenesulphonate as a Fluorescent Probe for the Study of the Binding of lophenoxic and lopanoic Acids to Human Serum Albumin. Molecular Pharmacology. 9(5). 649–657. 12 indexed citations

12.

Wade, D. N. & Gillian Sudlow. (1973). Fluorometric Measurement of 5-Fluorocytosine in Biological Fluids. Journal of Pharmaceutical Sciences. 62(5). 828–829. 14 indexed citations

13.

Sudlow, Gillian, Donald Birkett, & D. N. Wade. (1973). Spectroscopic techniques in the study of protein binding: the use of 1-anilino-8-naphthalenesulphonate as a fluorescent probe for the study of the binding of iophenoxic and iopanoic acids to human serum albumin.. PubMed. 9(5). 649–57. 30 indexed citations

14.

Wade, D. N. & Gillian Sudlow. (1972). The Kinetics of 5-Fluorocytosine Elimination in Man. Australian and New Zealand Journal of Medicine. 2(2). 153–158. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact